BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 18573937)

  • 1. Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.
    Labbé AC; Poirier L; Maccannell D; Louie T; Savoie M; Béliveau C; Laverdière M; Pépin J
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3180-7. PubMed ID: 18573937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018.
    Spigaglia P; Barbanti F; Dionisi AM; Mastrantonio P
    J Clin Microbiol; 2010 Aug; 48(8):2892-6. PubMed ID: 20554809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of Clostridium difficile-associated disease at University Hospital Basel including molecular characterisation of the isolates 2006-2007.
    Fenner L; Frei R; Gregory M; Dangel M; Stranden A; Widmer AF
    Eur J Clin Microbiol Infect Dis; 2008 Dec; 27(12):1201-7. PubMed ID: 18560909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile ribotype 027 is most prevalent among inpatients admitted from long-term care facilities.
    Archbald-Pannone LR; Boone JH; Carman RJ; Lyerly DM; Guerrant RL
    J Hosp Infect; 2014 Dec; 88(4):218-21. PubMed ID: 25228227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of resistance against erythromycin and moxifloxacin, presence of binary toxin gene and PCR ribotypes in Clostridium difficile isolates from 1990 and 2008.
    Ilchmann C; Zaiss NH; Speicher A; Christner M; Ackermann G; Rohde H
    Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1571-3. PubMed ID: 20632051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predominance of PCR-ribotypes, 018 (smz) and 369 (trf) of Clostridium difficile in Japan: a potential relationship with other global circulating strains?
    Senoh M; Kato H; Fukuda T; Niikawa A; Hori Y; Hagiya H; Ito Y; Miki H; Abe Y; Furuta K; Takeuchi H; Tajima H; Tominaga H; Satomura H; Kato H; Morita S; Tanada A; Hara T; Kawada M; Sato Y; Takahashi M; Higuchi A; Nakajima T; Wakamatsu Y; Toyokawa M; Ueda A; Roberts P; Miyajima F; Shibayama K
    J Med Microbiol; 2015 Oct; 64(10):1226-1236. PubMed ID: 26238868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First Polish outbreak of Clostridium difficile ribotype 027 infections among dialysis patients.
    Lachowicz D; Szulencka G; Obuch-Woszczatyński P; van Belkum A; Pituch H
    Eur J Clin Microbiol Infect Dis; 2015 Jan; 34(1):63-67. PubMed ID: 25060801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1.
    Akerlund T; Persson I; Unemo M; Norén T; Svenungsson B; Wullt M; Burman LG
    J Clin Microbiol; 2008 Apr; 46(4):1530-3. PubMed ID: 18287318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals.
    Nicholas A; Kim YK; Lee WK; Selasi GN; Na SH; Kwon HI; Kim YJ; Lee HS; Song KE; Shin JH; Lee JC
    PLoS One; 2017; 12(3):e0174716. PubMed ID: 28355266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains.
    Almutairi MS; Gonzales-Luna AJ; Alnezary FS; Fallatah SB; Alam MJ; Begum K; Garey KW
    Anaerobe; 2021 Dec; 72():102440. PubMed ID: 34461273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of Clostridium difficile PCR-ribotype 027 and it's closely related PCR-ribotype 176 in hospitals in Poland in 2008-2010.
    Obuch-Woszczatyński P; Lachowicz D; Schneider A; Mól A; Pawłowska J; Ożdżeńska-Milke E; Pruszczyk P; Wultańska D; Młynarczyk G; Harmanus C; Kuijper EJ; van Belkum A; Pituch H
    Anaerobe; 2014 Aug; 28():13-7. PubMed ID: 24799338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAP1 strain type predicts outcomes from Clostridium difficile infection.
    See I; Mu Y; Cohen J; Beldavs ZG; Winston LG; Dumyati G; Holzbauer S; Dunn J; Farley MM; Lyons C; Johnston H; Phipps E; Perlmutter R; Anderson L; Gerding DN; Lessa FC
    Clin Infect Dis; 2014 May; 58(10):1394-400. PubMed ID: 24604900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemic ribotypes of Clostridium (now Clostridioides) difficile are likely to be more virulent than non-epidemic ribotypes in animal models.
    Vitucci JC; Pulse M; Tabor-Simecka L; Simecka J
    BMC Microbiol; 2020 Feb; 20(1):27. PubMed ID: 32024477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing prevalence of the epidemic ribotype 106 in healthcare facility-associated and community-associated Clostridioides difficile infection.
    Suárez-Bode L; Barrón R; Pérez JL; Mena A
    Anaerobe; 2019 Feb; 55():124-129. PubMed ID: 30550807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks.
    López-Ureña D; Quesada-Gómez C; Montoya-Ramírez M; del Mar Gamboa-Coronado M; Somogyi T; Rodríguez C; Rodríguez-Cavallini E
    Emerg Microbes Infect; 2016 May; 5(5):e42. PubMed ID: 27165560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of rifampin resistance identified in an epidemic Clostridium difficile clone from a large teaching hospital.
    Curry SR; Marsh JW; Shutt KA; Muto CA; O'Leary MM; Saul MI; Pasculle AW; Harrison LH
    Clin Infect Dis; 2009 Feb; 48(4):425-9. PubMed ID: 19140738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribotyping of Clostridium difficile strains associated with nosocomial transmission and relapses in a Swedish County.
    Magnusson C; Wullt M; Löfgren S; Iveroth P; Akerlund T; Matussek A
    APMIS; 2013 Feb; 121(2):153-7. PubMed ID: 23030627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile infection in an Iranian hospital.
    Jalali M; Khorvash F; Warriner K; Weese JS
    BMC Res Notes; 2012 Mar; 5():159. PubMed ID: 22436392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in Southern Québec, Canada.
    Bourgault AM; Lamothe F; Loo VG; Poirier L;
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3473-5. PubMed ID: 17005836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced surveillance of Clostridium difficile infection occurring outside hospital, England, 2011 to 2013.
    Fawley WN; Davies KA; Morris T; Parnell P; Howe R; Wilcox MH;
    Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27487436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.